Zobrazeno 1 - 10
of 528
pro vyhledávání: '"Manning, JJ"'
Autor:
Green HM; Department of Pharmacology and Toxicology, School of Biomedical Sciences, University of Otago, Dunedin, New Zealand., Manning JJ; Department of Pharmacology and Toxicology, School of Biomedical Sciences, University of Otago, Dunedin, New Zealand., Greig IR; School of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Aberdeen, UK., Ross RA; Department of Pharmacology and Toxicology, University of Toronto, Toronto, Canada., Finlay DB; Department of Pharmacology and Toxicology, School of Biomedical Sciences, University of Otago, Dunedin, New Zealand., Glass M; Department of Pharmacology and Toxicology, School of Biomedical Sciences, University of Otago, Dunedin, New Zealand.
Publikováno v:
British journal of pharmacology [Br J Pharmacol] 2024 Oct; Vol. 181 (19), pp. 3642-3662. Date of Electronic Publication: 2024 Jun 03.
Autor:
Manning JJ; Department of Pharmacology and Toxicology, School of Biomedical Sciences, University of Otago, Dunedin, New Zealand., Finlay DB; Department of Pharmacology and Toxicology, School of Biomedical Sciences, University of Otago, Dunedin, New Zealand., Glass M; Department of Pharmacology and Toxicology, School of Biomedical Sciences, University of Otago, Dunedin, New Zealand. Electronic address: michelle.glass@otago.ac.nz.
Publikováno v:
Biochemical pharmacology [Biochem Pharmacol] 2024 Jun; Vol. 224, pp. 116190. Date of Electronic Publication: 2024 Apr 09.
Autor:
Zuo H; Department of Molecular Pharmacology and Therapeutics, Columbia University, New York, NY, USA., Park J; Department of Molecular Pharmacology and Therapeutics, Columbia University, New York, NY, USA., Frangaj A; Department of Molecular Pharmacology and Therapeutics, Columbia University, New York, NY, USA., Ye J; Department of Physiology and Cellular Biophysics, Columbia University, New York, NY, USA., Lu G; Department of Biological Sciences, Columbia University, New York, NY, USA., Manning JJ; Department of Psychiatry, Columbia University, New York, NY, USA.; Division of Molecular Therapeutics, New York State Psychiatric Institute, New York, NY, USA., Asher WB; Department of Psychiatry, Columbia University, New York, NY, USA.; Division of Molecular Therapeutics, New York State Psychiatric Institute, New York, NY, USA., Lu Z; Department of Biological Sciences, Columbia University, New York, NY, USA., Hu GB; Laboratory for BioMolecular Structure, Brookhaven National Laboratory, Upton, NY, USA., Wang L; Laboratory for BioMolecular Structure, Brookhaven National Laboratory, Upton, NY, USA., Mendez J; National Center for Cryo-EM Access and Training, Simons Electron Microscopy Center, New York Structural Biology Center, New York, NY, USA., Eng E; National Center for Cryo-EM Access and Training, Simons Electron Microscopy Center, New York Structural Biology Center, New York, NY, USA., Zhang Z; Department of Biochemistry and Molecular Biophysics, Columbia University, New York, NY, USA., Lin X; Department of Psychiatry, Columbia University, New York, NY, USA.; Division of Molecular Therapeutics, New York State Psychiatric Institute, New York, NY, USA., Grassucci R; Department of Biochemistry and Molecular Biophysics, Columbia University, New York, NY, USA., Hendrickson WA; Department of Physiology and Cellular Biophysics, Columbia University, New York, NY, USA.; Department of Biochemistry and Molecular Biophysics, Columbia University, New York, NY, USA., Clarke OB; Department of Physiology and Cellular Biophysics, Columbia University, New York, NY, USA.; Department of Anesthesiology, Columbia University, New York, NY, USA.; Irving Institute for Clinical and Translational Research, Columbia University, New York, NY, USA., Javitch JA; Department of Molecular Pharmacology and Therapeutics, Columbia University, New York, NY, USA. Jonathan.Javitch@nyspi.columbia.edu.; Department of Physiology and Cellular Biophysics, Columbia University, New York, NY, USA. Jonathan.Javitch@nyspi.columbia.edu.; Department of Psychiatry, Columbia University, New York, NY, USA. Jonathan.Javitch@nyspi.columbia.edu.; Division of Molecular Therapeutics, New York State Psychiatric Institute, New York, NY, USA. Jonathan.Javitch@nyspi.columbia.edu., Conigrave AD; School of Life & Environmental Sciences, Charles Perkins Centre, University of Sydney, Camperdown, New South Wales, Australia. arthur.conigrave@sydney.edu.au., Fan QR; Department of Molecular Pharmacology and Therapeutics, Columbia University, New York, NY, USA. qf13@cumc.columbia.edu.; Department of Pathology and Cell Biology, Columbia University, New York, NY, USA. qf13@cumc.columbia.edu.
Publikováno v:
Nature [Nature] 2024 May; Vol. 629 (8011), pp. 481-488. Date of Electronic Publication: 2024 Apr 17.
Autor:
Lee KH; Computational Chemistry and Molecular Biophysics Section, Molecular Targets and Medications Discovery Branch, National Institute on Drug Abuse─Intramural Research Program, National Institutes of Health, Baltimore, Maryland 21224, United States., Manning JJ; Division of Molecular Therapeutics, New York State Psychiatric Institute, New York, New York 10032, United States.; Department of Molecular Pharmacology and Therapeutics, Vagelos College of Physicians and Surgeons, Columbia University, New York, New York 10032, United States.; Department of Psychiatry, Vagelos College of Physicians and Surgeons, Columbia University, New York, New York 10032, United States., Javitch J; Division of Molecular Therapeutics, New York State Psychiatric Institute, New York, New York 10032, United States.; Department of Molecular Pharmacology and Therapeutics, Vagelos College of Physicians and Surgeons, Columbia University, New York, New York 10032, United States.; Department of Psychiatry, Vagelos College of Physicians and Surgeons, Columbia University, New York, New York 10032, United States., Shi L; Computational Chemistry and Molecular Biophysics Section, Molecular Targets and Medications Discovery Branch, National Institute on Drug Abuse─Intramural Research Program, National Institutes of Health, Baltimore, Maryland 21224, United States.
Publikováno v:
Journal of chemical information and modeling [J Chem Inf Model] 2023 Aug 28; Vol. 63 (16), pp. 5001-5017. Date of Electronic Publication: 2023 Aug 04.
Autor:
Meszaros J; Department of Psychiatry, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY, United States.; Division of Molecular Therapeutics, New York State Psychiatric Institute, New York, NY, United States., Geggier P; Department of Psychiatry, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY, United States.; Division of Molecular Therapeutics, New York State Psychiatric Institute, New York, NY, United States., Manning JJ; Department of Psychiatry, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY, United States.; Division of Molecular Therapeutics, New York State Psychiatric Institute, New York, NY, United States., Asher WB; Department of Psychiatry, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY, United States.; Division of Molecular Therapeutics, New York State Psychiatric Institute, New York, NY, United States., Javitch JA; Department of Psychiatry, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY, United States.; Division of Molecular Therapeutics, New York State Psychiatric Institute, New York, NY, United States.; Department of Molecular Pharmacology and Therapeutics, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY, United States.; Department of Physiology and Cellular Biophysics, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY, United States.
Publikováno v:
Frontiers in cell and developmental biology [Front Cell Dev Biol] 2023 Aug 15; Vol. 11, pp. 1184077. Date of Electronic Publication: 2023 Aug 15 (Print Publication: 2023).
Autor:
Manning JJ; Department of Pharmacology and Toxicology, School of Biomedical Sciences, University of Otago, Dunedin, New Zealand., Rawcliffe G; Department of Pharmacology and Toxicology, School of Biomedical Sciences, University of Otago, Dunedin, New Zealand., Finlay DB; Department of Pharmacology and Toxicology, School of Biomedical Sciences, University of Otago, Dunedin, New Zealand., Glass M; Department of Pharmacology and Toxicology, School of Biomedical Sciences, University of Otago, Dunedin, New Zealand.
Publikováno v:
British journal of pharmacology [Br J Pharmacol] 2023 Feb; Vol. 180 (3), pp. 369-382. Date of Electronic Publication: 2022 Nov 06.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Kevin RC; The Lambert Initiative for Cannabinoid Therapeutics, Brain and Mind Centre, The University of Sydney, NSW 2050, Australia.; School of Pharmacy, The University of Sydney, NSW 2006, Australia., Mirlohi S; Faculty of Medicine, Health and Human Sciences, Macquarie University, NSW 2109, Australia., Manning JJ; Department of Pharmacology and Toxicology, University of Otago, Dunedin 9016, New Zealand., Boyd R; The Lambert Initiative for Cannabinoid Therapeutics, Brain and Mind Centre, The University of Sydney, NSW 2050, Australia.; School of Chemistry, The University of Sydney, NSW 2006, Australia., Cairns EA; The Lambert Initiative for Cannabinoid Therapeutics, Brain and Mind Centre, The University of Sydney, NSW 2050, Australia.; School of Psychology, The University of Sydney, NSW 2006, Australia., Ametovski A; The Lambert Initiative for Cannabinoid Therapeutics, Brain and Mind Centre, The University of Sydney, NSW 2050, Australia.; School of Chemistry, The University of Sydney, NSW 2006, Australia., Lai F; School of Pharmacy, The University of Sydney, NSW 2006, Australia., Luo JL; The Lambert Initiative for Cannabinoid Therapeutics, Brain and Mind Centre, The University of Sydney, NSW 2050, Australia.; School of Psychology, The University of Sydney, NSW 2006, Australia., Jorgensen W; School of Chemistry, The University of Sydney, NSW 2006, Australia., Ellison R; Clinical Toxicology and Environmental Biomonitoring Laboratory, University of California, San Francisco, California 94143, United States., Gerona RR; Clinical Toxicology and Environmental Biomonitoring Laboratory, University of California, San Francisco, California 94143, United States., Hibbs DE; School of Pharmacy, The University of Sydney, NSW 2006, Australia., McGregor IS; The Lambert Initiative for Cannabinoid Therapeutics, Brain and Mind Centre, The University of Sydney, NSW 2050, Australia.; School of Psychology, The University of Sydney, NSW 2006, Australia., Glass M; Department of Pharmacology and Toxicology, University of Otago, Dunedin 9016, New Zealand., Connor M; Faculty of Medicine, Health and Human Sciences, Macquarie University, NSW 2109, Australia., Bladen C; Faculty of Medicine, Health and Human Sciences, Macquarie University, NSW 2109, Australia.; Department of Physiology and Pharmacology, Hotchkiss Brain Institute, Alberta Children's Hospital Research Institute, Cumming School of Medicine, University of Calgary, Calgary, AB T2N 1N4, Canada., Zamponi GW; Department of Physiology and Pharmacology, Hotchkiss Brain Institute, Alberta Children's Hospital Research Institute, Cumming School of Medicine, University of Calgary, Calgary, AB T2N 1N4, Canada., Banister SD; The Lambert Initiative for Cannabinoid Therapeutics, Brain and Mind Centre, The University of Sydney, NSW 2050, Australia.; School of Chemistry, The University of Sydney, NSW 2006, Australia.
Publikováno v:
ACS chemical neuroscience [ACS Chem Neurosci] 2022 May 04; Vol. 13 (9), pp. 1395-1409. Date of Electronic Publication: 2022 Apr 20.
Autor:
Markham J; The Lambert Initiative for Cannabinoid Therapeutics, Brain and Mind Centre, The University of Sydney, Sydney 2050, New South Wales, Australia.; School of Chemistry, The University of Sydney, Sydney 2006, New South Wales, Australia., Sparkes E; The Lambert Initiative for Cannabinoid Therapeutics, Brain and Mind Centre, The University of Sydney, Sydney 2050, New South Wales, Australia.; School of Chemistry, The University of Sydney, Sydney 2006, New South Wales, Australia., Boyd R; The Lambert Initiative for Cannabinoid Therapeutics, Brain and Mind Centre, The University of Sydney, Sydney 2050, New South Wales, Australia.; School of Chemistry, The University of Sydney, Sydney 2006, New South Wales, Australia., Chen S; Department of Pharmacology and Toxicology, University of Otago, Dunedin 9016, New Zealand., Manning JJ; Department of Pharmacology and Toxicology, University of Otago, Dunedin 9016, New Zealand., Finlay D; Department of Pharmacology and Toxicology, University of Otago, Dunedin 9016, New Zealand., Lai F; School of Pharmacy, The University of Sydney, Sydney 2006, New South Wales, Australia., McGregor E; The Lambert Initiative for Cannabinoid Therapeutics, Brain and Mind Centre, The University of Sydney, Sydney 2050, New South Wales, Australia.; School of Psychology, The University of Sydney, Sydney 2005, New South Wales, Australia., Maloney CJ; The Lambert Initiative for Cannabinoid Therapeutics, Brain and Mind Centre, The University of Sydney, Sydney 2050, New South Wales, Australia.; School of Chemistry, The University of Sydney, Sydney 2006, New South Wales, Australia., Gerona RR; Clinical Toxicology and Environmental Biomonitoring Laboratory, University of California, San Francisco, California 94143, United States., Connor M; Faculty of Medicine and Health Sciences, Macquarie University, Sydney 2109, New South Wales, Australia., McGregor IS; The Lambert Initiative for Cannabinoid Therapeutics, Brain and Mind Centre, The University of Sydney, Sydney 2050, New South Wales, Australia.; School of Psychology, The University of Sydney, Sydney 2005, New South Wales, Australia., Hibbs DE; School of Pharmacy, The University of Sydney, Sydney 2006, New South Wales, Australia., Glass M; Department of Pharmacology and Toxicology, University of Otago, Dunedin 9016, New Zealand., Kevin RC; The Lambert Initiative for Cannabinoid Therapeutics, Brain and Mind Centre, The University of Sydney, Sydney 2050, New South Wales, Australia.; School of Pharmacy, The University of Sydney, Sydney 2006, New South Wales, Australia., Banister SD; The Lambert Initiative for Cannabinoid Therapeutics, Brain and Mind Centre, The University of Sydney, Sydney 2050, New South Wales, Australia.; School of Chemistry, The University of Sydney, Sydney 2006, New South Wales, Australia.
Publikováno v:
ACS chemical neuroscience [ACS Chem Neurosci] 2022 Apr 20; Vol. 13 (8), pp. 1281-1295. Date of Electronic Publication: 2022 Apr 11.
Autor:
Manning JJ; Department of Pharmacology and Toxicology, University of Otago, Dunedin, New Zealand, PO Box 56, Dunedin, 9054, New Zealand., Green HM; Department of Pharmacology and Toxicology, University of Otago, Dunedin, New Zealand, PO Box 56, Dunedin, 9054, New Zealand., Glass M; Department of Pharmacology and Toxicology, University of Otago, Dunedin, New Zealand, PO Box 56, Dunedin, 9054, New Zealand., Finlay DB; Department of Pharmacology and Toxicology, University of Otago, Dunedin, New Zealand, PO Box 56, Dunedin, 9054, New Zealand. Electronic address: david.finlay@otago.ac.nz.
Publikováno v:
Neuropharmacology [Neuropharmacology] 2021 Aug 01; Vol. 193, pp. 108611. Date of Electronic Publication: 2021 May 15.